立方制药
(003020)
| 流通市值：24.74亿 | | | 总市值：34.56亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 502,928,970.18 | 202,708,102.33 | 236,538,853.93 | 296,244,026.83 |
| 应收票据及应收账款 | 259,239,324.51 | 236,561,188.77 | 189,427,669.97 | 465,767,277.87 |
| 其中：应收票据 | 792,000 | 807,500 | - | - |
| 应收账款 | 258,447,324.51 | 235,753,688.77 | 189,427,669.97 | 465,767,277.87 |
| 应收款项融资 | 35,946,606.26 | 26,384,756.45 | 39,568,864.72 | 39,080,015.46 |
| 预付款项 | 9,359,458.77 | 24,234,674 | 18,282,279.51 | 49,717,532 |
| 其他应收款合计 | 19,973,528.21 | 40,734,741.01 | 74,036,943.16 | 9,789,634.49 |
| 应收股利 | 4,956,463.07 | 34,956,463.07 | 69,308,639.92 | - |
| 存货 | 242,914,365.17 | 258,715,204.4 | 172,736,109.66 | 373,038,456.99 |
| 其他流动资产 | 19,264,693.94 | 17,545,488.6 | 15,633,706.78 | 13,294,782.34 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,151,146,569.82 | 1,073,366,087.7 | 1,072,710,205.4 | 1,557,043,251.17 |
| 非流动资产: | | | | |
| 长期股权投资 | 163,951,200.01 | 157,051,879.85 | 157,746,451.6 | 43,735,288.33 |
| 其他权益工具投资 | 16,439,136.58 | 1,439,136.58 | - | - |
| 投资性房地产 | 25,617,258.87 | 32,978,929.56 | 28,471,261.68 | 24,048,102.6 |
| 固定资产 | 427,255,044.92 | 277,366,327.63 | 152,797,084.19 | 158,138,172.35 |
| 在建工程 | 459,661,247.6 | 450,122,347.54 | 425,594,505.15 | 398,108,505.49 |
| 生产性生物资产 | 2,403,399.61 | 2,403,399.61 | - | - |
| 使用权资产 | 9,300,017.93 | 10,556,045.85 | 11,003,568.86 | 13,093,832.9 |
| 无形资产 | 113,285,091.8 | 101,626,974.03 | 76,009,722.55 | 82,452,218.46 |
| 开发支出 | 2,084,400 | 2,150,400 | 1,400,400 | 1,033,200 |
| 商誉 | 74,440,520.92 | 73,526,992.55 | - | - |
| 长期待摊费用 | 5,324,735.71 | 5,464,439.91 | 5,214,788.11 | 5,714,011.5 |
| 递延所得税资产 | 16,129,089.54 | 12,318,526.65 | 12,936,414.01 | 10,837,430.02 |
| 其他非流动资产 | 16,641,861.86 | 16,779,296.87 | 15,464,513 | 11,821,252 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,332,533,005.35 | 1,143,784,696.63 | 886,638,709.15 | 748,982,013.65 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,483,679,575.17 | 2,217,150,784.33 | 1,959,348,914.55 | 2,306,025,264.82 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 41,993,968.44 |
| 应付票据及应付账款 | 301,250,508.41 | 290,068,732.83 | 234,799,996.6 | 546,252,103.12 |
| 其中：应付票据 | 0 | - | - | 194,014,162.39 |
| 应付账款 | 301,250,508.41 | 290,068,732.83 | 234,799,996.6 | 352,237,940.73 |
| 预收款项 | 276,402.45 | - | 258,928.64 | - |
| 合同负债 | 10,707,378.82 | 19,250,664.93 | 17,671,522.84 | 21,037,747.42 |
| 应付职工薪酬 | 32,376,327.81 | 24,515,406.16 | 21,572,618.32 | 16,706,121.51 |
| 应交税费 | 35,938,630.14 | 20,742,476.77 | 29,858,209.79 | 40,434,836.61 |
| 其他应付款合计 | 156,412,962.45 | 74,120,976.25 | 64,204,870.84 | 55,839,082.5 |
| 应付股利 | 15,680,000 | - | - | - |
| 一年内到期的非流动负债 | 4,537,637.07 | 5,362,000.82 | 4,943,896.31 | 9,585,520.96 |
| 其他流动负债 | 1,229,435.73 | 2,799,560.22 | 2,231,316.89 | 4,275,065.54 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 542,729,282.88 | 436,859,817.98 | 375,541,360.23 | 736,124,446.1 |
| 非流动负债: | | | | |
| 长期借款 | 31,014,208.33 | - | - | - |
| 租赁负债 | 2,842,254.77 | 3,157,703.84 | 4,496,891.29 | 2,046,937.53 |
| 长期应付款 | - | 1,160,000 | 1,160,000 | 1,160,000 |
| 递延收益 | 20,163,577.11 | 14,069,364.77 | 11,983,546.51 | 12,481,114.09 |
| 递延所得税负债 | 13,432,237.41 | 11,055,115.94 | 4,280,101.58 | 1,421,209.86 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 67,452,277.62 | 29,442,184.55 | 21,920,539.38 | 17,109,261.48 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 610,181,560.5 | 466,302,002.53 | 397,461,899.61 | 753,233,707.58 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 159,675,100 | 159,675,100 | 159,207,100 | 122,467,000 |
| 资本公积 | 551,889,778.53 | 540,359,792.46 | 529,962,964.54 | 561,361,676.93 |
| 减:库存股 | 20,985,151.32 | 31,650,270 | 27,045,150 | 27,045,150 |
| 盈余公积 | 81,977,401.19 | 65,506,032.53 | 64,232,505.29 | 63,373,351.19 |
| 未分配利润 | 912,969,213.21 | 870,857,727.27 | 835,529,595.11 | 832,634,679.12 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,685,526,341.61 | 1,604,748,382.26 | 1,561,887,014.94 | 1,552,791,557.24 |
| 少数股东权益 | 187,971,673.06 | 146,100,399.54 | - | - |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,873,498,014.67 | 1,750,848,781.8 | 1,561,887,014.94 | 1,552,791,557.24 |
| 负债和股东权益合计 | 2,483,679,575.17 | 2,217,150,784.33 | 1,959,348,914.55 | 2,306,025,264.82 |
| 公告日期 | 2024-04-23 | 2023-10-31 | 2023-08-29 | 2023-04-18 |
| 审计意见(境内) | 标准无保留意见 | | | |